Affiliation:
1. Department of Clinical Pharmacology; Genentech Research and Early Development; South San Francisco California USA
Subject
Pharmacology (medical),Pharmacology
Reference5 articles.
1. Application of physiologically based pharmacokinetic (PBPK) modeling to support dose selection: report of an FDA public workshop on PBPK;Wagner;CPT Pharmacometrics Syst. Pharmacol.,2015
2. European Medicines Agency Draft guideline on the qualification and reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500211315.pdf 2016
3. Recent advances in development and application of physiologically-based pharmacokinetic (PBPK) models: a transition from academic curiosity to regulatory acceptance;Jamei;Curr. Pharmacol. Rep.,2016
4. Physiologically based pharmacokinetic modeling in regulatory decision-making at the European Medicines Agency;Luzon;Clin. Pharmacol. Ther.,2016
5. Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective;Jones;Clin. Pharmacol. Ther.,2015
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献